. 2014 Oct 10;14:757. doi: 10.1186/1471-2407-14-757

Table 2.

Provision of cancer care to breast cancer patients without distant metastasis by age

Treatment	Category	Overall		15-69 years		> = 70 years
		N	%	N	%	N	%
Overall		4025		2691		1334
Local treatment	Available	3038	75.5	2078	77.2	960	72.0
	BCS^a	316	10.4	187	9.0	129	13.4
	BCS + radiotherapy^a	1716	56.5	1342	64.6	374	39.0
	Mastectomy^a	558	18.4	262	12.6	296	30.8
	Mastectomy + radiotherapy^a	424	14.0	284	13.7	140	14.6
	No surgery^a	24	0.8	3	0.1	21	2.2
Lymph node dissection	Available	3043	75.6	2145	79.7	898	67.3
	ALND^a	1274	41.9	812	37.9	462	51.4
	SND^a	1139	37.4	849	39.6	290	32.3
	SND + ALND^a	525	17.3	432	20.1	93	10.4
	None^a	47	1.5	7	0.3	40	4.5
Chemotherapy^b	Available	1571	86.2	1154	91.4	417	74.5
	Yes^a	1215	77.3	1050	91.0	165	39.6
	None^a	356	22.7	104	9.0	252	60.4
Antiestrogen treatment^c	Available	2232	75.8	1556	80.0	676	67.6
	Yes^a	2035	91.2	1433	92.1	602	89.1
	None^a	197	8.8	123	7.9	73	10.9
Targeted therapy^d	Available	443	55.7	325	58.9	118	48.4
	Yes^a	188	42.4	164	50.5	24	20.3
	None^a	255	57.6	161	49.5	94	79.7

Local treatment, lymph node dissection and adjuvant systemic treatment of female BRC patients without distant metastases (ICD-10: C50) from Saarland diagnosed between 2005 and 2009. BCS: breast conserving surgery; ALND: axillary lymph node dissection; SND: sentinel node dissection; a) proportions among patients with available information; b) among patients with positive lymph nodes or hormone receptor negative tumors; c) among patients with hormone receptor positive or mixed tumors; d) among patients with HER2/neu expressed tumors; patients presenting with distant metastases or DCO notified tumors were excluded.